Amid Avastin Noise, Shire Quietly Awaits Word On ProAmatine Public Hearing

The jury is still out on whether Shire’s hypotension drug ProAmatine (midodrine) will be the focus of the same type of public hearing recently held on the fate of Avastin’s metastatic breast cancer claim.